Controversial cholesterol-lowering drug 'vindicated' in global study

November 18, 2014 4:08 PM

3 0

Controversial cholesterol-lowering drug 'vindicated' in global study

Lead author Dr. Christopher P. Cannon, a professor of medicine at Harvard Medical School and physician at Brigham and Women's Hospital - both in Boston, MA - says their study "is the first to show that adding a non-statin drug to a statin to improve cholesterol levels can help patients with specific heart problems do better."

Called IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial), the study involved 1,158 centers across 39 countries and enrolled a total of 18,144 participants who were followed for an average of 6 years.

Read more

To category page

Loading...